Dr. Hussein Abdul-Hassan Tawbi on Oral Azacitidine Plus Pembrolizumab in Metastatic Melanoma

Leggi l'articolo originale


Cancer Network spoke with Hussein Abdul-Hassan Tawbi, MD, PhD, on the results of a phase II study of oral azacitidine in combination with pembrolizumab in metastatic melanoma.

Lascia un commento